How should I manage a patient with a critically elevated plasma ammonia level of 149 µmol/L?

Management of Critical Ammonia Level 149 µmol/L

Immediately initiate nitrogen-scavenging therapy and prepare for potential dialysis if the patient shows any neurological deterioration, as this ammonia level (149 µmol/L) sits at the critical threshold where continuous kidney replacement therapy (CKRT) becomes indicated with rapidly deteriorating neurological status. 1

Immediate Assessment & Stabilization

Perform urgent neurological examination to determine encephalopathy grade:

• Moderate encephalopathy: lethargy, decreased activity, hypotonia, weak reflexes, constricted pupils, bradycardia
• Severe encephalopathy: stupor/coma, no activity, decerebrate posture, flaccid tone, absent reflexes, non-reactive pupils 1

Measure ammonia correctly if not already done properly (fasting patient, no tourniquet, EDTA tube on ice, transport within 60-90 minutes at +4°C) 2. A normal ammonia level has high negative predictive value and should prompt investigation for alternative causes of altered mental status 3, 2.

Non-Kidney Replacement Therapy (NKRT) - Start Immediately

Stop all protein intake immediately and initiate the following 1:

Nutritional Support

• IV glucose: 8-10 mg/kg/min infusion rate
• IV lipids: 0.5 g/kg daily (up to 3 g/kg daily)
• Total calories: ≥100 kcal/kg daily
• Protein reintroduction: Gradually add 0.25 g/kg daily up to 1.5 g/kg daily within 48 hours once stabilized

Nitrogen-Scavenging Agents (Dosing based on body weight)

For patients <20 kg:

• IV sodium benzoate: 250 mg/kg (maximum 12 g daily total)
• IV sodium phenylacetate: 250 mg/kg
• Give over 90 minutes as bolus, then continuous maintenance over 24 hours

For patients >20 kg:

• IV sodium benzoate: 5.5 g/m²
• IV sodium phenylacetate: 5.5 g/m²
• Give over 90 minutes as bolus, then continuous maintenance over 24 hours

Urea Cycle Intermediates

L-arginine hydrochloride (given over 90 min as bolus then maintenance over 24h):

• <20 kg: 200 mg/kg (for OTC/CPS deficiencies) or 600 mg/kg (for ASS/ASL deficiencies)
• >20 kg: 4 g/m² (for OTC/CPS deficiencies) or 12 g/m² (for ASS/ASL deficiencies)

Caution: Arginine can cause hypotension; titrate carefully, especially if dialysis is initiated 1

Decision Point: When to Initiate Dialysis

CKRT (specifically high-dose CVVHD) should be initiated immediately if ANY of the following occur 1:

1. Rapidly deteriorating neurological status, coma, or cerebral edema with ammonia >150 µmol/L (your patient is at this threshold)
2. Moderate or severe encephalopathy (as defined above)
3. Ammonia persistently >400 µmol/L despite NKRT measures
4. Rapid rise to >300 µmol/L within hours uncontrolled by medical therapy

Why CKRT Over Other Modalities

High-dose continuous venovenous hemodialysis (CVVHD) is first-line because it:

• Maintains hemodynamic stability (critical for preventing cerebral edema worsening)
• Reduces rebound hyperammonemia compared to intermittent HD
• Achieves 50% ammonia reduction in 2-14 hours 1
• Avoids rapid osmotic shifts that worsen intracranial pressure 1

Peritoneal dialysis is inadequate and should only be used if extracorporeal therapies are unavailable 1

CKRT Technical Parameters

Standard CKRT dosing:

• Blood flow rate (Qb): 30-50 ml/min
• Dialysate flow rate (Qd)/Qb ratio: >1.5
• Use warmed dialysate for hemodynamic stability 1

High-dose CKRT (for ammonia >1,000 µmol/L):

• Qb: 30-50 ml/min
• Qd: aim for >1,000 ml/h
• Target clearance rates up to 8,000 ml/1.73 m²/h 1

Step down CKRT when ammonia <200 µmol/L on two consecutive hourly measurements 1

Critical Prognostic Factor

The duration of hyperammonemic coma before dialysis initiation is the most important prognostic factor - not the rate of ammonia clearance 1. This emphasizes the urgency of early intervention at your patient's current level of 149 µmol/L if neurological symptoms are present or worsening.

Differential Diagnosis Considerations

If ammonia is truly normal on proper sampling, strongly reconsider the diagnosis 3, 2. In adults with hyperammonemia and minimal/no liver disease, consider:

• Urea cycle disorders (especially ornithine transcarbamylase deficiency - most common in adults) 4, 5
• Sepsis with urea-splitting organisms 6
• Drug-induced (valproate, chemotherapy)
• Post-transplant complications 7

Obtain brain imaging (CT or MRI) if diagnostic doubt exists or patient fails to respond to treatment, primarily to exclude intracranial hemorrhage or other structural lesions 3, 2

Common Pitfalls to Avoid

1. Delaying dialysis while waiting for NKRT response in patients with neurological deterioration - cerebral edema risk exceeds 55% when ammonia >200 µmol/L 5
2. Improper ammonia sampling leading to falsely elevated results (hemolysis, delayed transport, room temperature)
3. Continuing protein intake which drives further ammonia production through catabolism
4. Using peritoneal dialysis when CKRT/HD is available
5. Overlooking non-hepatic causes in patients with normal liver function tests